Mark Scapens
Direttore/Membro del Consiglio presso CANNASOUTH LIMITED
Posizioni attive di Mark Scapens
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CANNASOUTH LIMITED | Direttore/Membro del Consiglio | - | - |
Eqalis Pharmaceuticals Ltd
 Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Mark Scapens
Precedenti posizioni note di Mark Scapens
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Aspire2 Group Ltd.
 Aspire2 Group Ltd. Miscellaneous Commercial ServicesCommercial Services Aspire2 Group Ltd. provide education and vocational training to domestic, international and business to business students. The firm offers private tertiary education and professional and vocational training. The company is headquartered in Auckland, New Zealand. | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
| Nuova-Zelanda | 4 |
Posizioni
| Director/Board Member | 3 |
Settori
| Health Technology | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CANNASOUTH LIMITED | Health Technology |
| Aziende private | 2 |
|---|---|
Aspire2 Group Ltd.
Aspire2 Group Ltd. Miscellaneous Commercial ServicesCommercial Services Aspire2 Group Ltd. provide education and vocational training to domestic, international and business to business students. The firm offers private tertiary education and professional and vocational training. The company is headquartered in Auckland, New Zealand. | Commercial Services |
Eqalis Pharmaceuticals Ltd
Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Health Technology |
- Borsa valori
- Insiders
- Mark Scapens
- Esperienza
